A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer
Clinical trial NCT04750382 · UNKNOWN
Trial details
- NCT number
- NCT04750382
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2020-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.